Pyridoxine/doxylamine
Commons · Question 72141 · Tabled 29 Aug 2025 · Department for Work and Pensions · Official record
Answered 10 Sep 2025
Question
Asked by Edward Morello
To ask the Secretary of State for Work and Pensions, whether his Department has made an assessment of the adequacy of the level of Personal Independence Payments for people affected by long-term conditions associated with in utero exposure to Debendox.
Answer
Answered by Sir Stephen Timms, 10 Sep 2025
Personal Independence Payment (PIP) provides a contribution towards the extra costs that may arise from a long-term disability or health condition. Entitlement to PIP focuses on the functional impacts of a person’s health condition or disability on thei...